FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katleen De Preter

Research Profile

Disorders

Neuroblastoma

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Johannes H Schulte; S Schulte; F Speleman; T Thor; J Vandesompele; Rogier Versteeg; A Bohrer; Katleen De Preter; Angelika Eggert; Lukas Heukamp; A Künkele; S Lefever; S Lindner; J Maurer; J Molenaar; H Schorle; Alexander Schramm
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Candy Kumps; Geneviève Laureys; Steve Lefever; Björn Menten; Pieter Mestdagh; Rosa Noguera; Filip Pattyn; Tom Sante; Alexander Schramm; Johannes H Schulte; Valérie Combaret; Sara De Brouwer; Katleen De Preter; Christine Devalck; Angelika Eggert; Annelies Fieuw; Tom Van Maerken; Nadine Van Roy; Jo Vandesompele; Frank Westermann; Frank Speleman
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
Jan M Ruijter; Robert G Rutledge; Davide Sisti; Andrej N Spiess; Jochen Blom; Gregory Boggy; Katleen De Preter; Stefaan Derveaux; Jan Hellemans; Antoon Lievens; Michael W Pfaffl; Sheng Zhao; Jo Vandesompele
Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katleen De Preter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johannes H Schulte; S Schulte; F Speleman; T Thor; J Vandesompele; Rogier Versteeg; A Bohrer; Katleen De Preter; Angelika Eggert; Lukas Heukamp; A Künkele; S Lefever; S Lindner; J Maurer; J Molenaar; H Schorle; Alexander Schramm
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Oncogene 2013;32(8):1059-65.
2013: Candy Kumps; Geneviève Laureys; Steve Lefever; Björn Menten; Pieter Mestdagh; Rosa Noguera; Filip Pattyn; Tom Sante; Alexander Schramm; Johannes H Schulte; Valérie Combaret; Sara De Brouwer; Katleen De Preter; Christine Devalck; Angelika Eggert; Annelies Fieuw; Tom Van Maerken; Nadine Van Roy; Jo Vandesompele; Frank Westermann; Frank Speleman
Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
PloS one 2013;8(1):e52321.
2013: Jan M Ruijter; Robert G Rutledge; Davide Sisti; Andrej N Spiess; Jochen Blom; Gregory Boggy; Katleen De Preter; Stefaan Derveaux; Jan Hellemans; Antoon Lievens; Michael W Pfaffl; Sheng Zhao; Jo Vandesompele
Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications.
Methods (San Diego, Calif.) 2013;59(1):32-46.
2012: Alexander Schramm; F Speleman; J Vandesompele; J Vermeulen; R Versteeg; Katleen De Preter; Angelika Eggert; K Fielitz; M Heilmann; J Koster; J Köster; T Marschall; M Martin; K Morik; R Noguera; S Rahmann; B Schowe; Johannes H Schulte
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome.
British journal of cancer 2012;107(8):1409-17.
2012: Lukas Heukamp; Katharina König; Steffi Kuhfittig-Kulle; Candy Kumps; Annette Künkele; Sven Lindner; Lydia Meder; Björn Menten; Pieter Mestdagh; Andrea Odersky; Filip Pattyn; Martin Peifer; Alexander Schramm; Reinhard Büttner; Sampurna Chatterjee; Katleen De Preter; Bram De Wilde; Angelika Eggert; Stefanie Schulte; Frank Speleman; Annika Spruessel; Theresa Thor; Roland T Ullrich; Jo Vandesompele; Johannes H Schulte
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.
Science translational medicine 2012;4(141):141ra91.
2012: Annette Künkele; Michel Mittelbronn; Kristian W Pajtler; Alexander Schramm; Katleen De Preter; Hedwig E Deubzer; Angelika Eggert; Michael A Grotzer; Wolfgang Hartmann; Lukas Heukamp; Frank Speleman; Theresa Thor; Johannes H Schulte
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
Neuro-oncology 2012;14(7):859-69.
2012: Annelies Fieuw; Candy Kumps; Björn Menten; Rosa Noguera; Filip Pattyn; Alexander Schramm; Johannes H Schulte; Francesca Antonacci; Patrick Buckley; Anne De Paepe; Katleen De Preter; Angelika Eggert; Raymond L Stallings; Peter Sudmant; Nadine Van Roy; Jo Vandesompele; Sarah Vergult; Rogier Versteeg; Frank Speleman
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas.
International journal of cancer. Journal international du cancer 2012;130(11):2599-606.
2012: Sara De Brouwer; Anne De Paepe; Katleen De Preter; Irina Lambertz; Pieter Mestdagh; Filip Pattyn; Alexander Schramm; Christina Schroeder; Johannes H Schulte; Jo Vandesompele; Frank Westermann; Frank Speleman
Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma.
International journal of cancer. Journal international du cancer 2012;130(11):2591-8.
2012: Annelies Fieuw; Frank Speleman; Jo Vandesompele; Bram De Wilde; Katleen De Preter
Cancer gene prioritization for targeted resequencing using FitSNP scores.
PloS one 2012;7(3):e31333.
2012: Tim Lammens; Klaus Beiske; Yves Benoit; Marc Bracke; Sara De Brouwer; Annemie De Craemer; Katleen De Preter; Lara Derycke; Jan Philippé; Frank Speleman; Katrien Swerts; Nadine Van Roy; Jo Vandesompele; Geneviève Laureys
N-cadherin in neuroblastoma disease: expression and clinical significance.
PloS one 2012;7(2):e31206.
2012: Jan J Molenaar; Ingrid Øra; Frank Speleman; Peter G van Sluis; Huib N Caron; Katleen De Preter; Marli E Ebus; David Gisselsson; Jan Koster; Ellen M Westerhout; Rogier Versteeg
Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis.
Genes, chromosomes & cancer 2012;51(1):10-9.
2011: Katleen De Preter; Elzbieta Drozynska; Angelika Eggert; Michael D Hogarty; Ewa Izycka-Swieszewska; Geneviève Laureys; Wendy B London; Pieter Mestdagh; Jan J Molenaar; Arlene Naranjo; Rosa Noguera; Marta Piqueras; Benjamin Schowe; Alexander Schramm; Johannes H Schulte; Frank Speleman; Raymond L Stallings; Nadine Van Roy; Peter van Sluis; Isabella Bray; Kenneth Bryan; Victoria Castel; Caifu Chen; Joëlle Vermeulen; Rogier Versteeg; Fjoralba Zeka; Jo Vandesompele
miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(24):7684-92.
2011: Sandra Acosta; Katleen De Preter; Carmen de Torres; Idoia Garcia; Candy Kumps; Cinzia Lavarino; Gemma Mayol; Eva Rodríguez; Jaume Mora
Identification of tumoral glial precursor cells in neuroblastoma.
Cancer letters 2011;312(1):73-81.
2011: Frank Speleman; Katleen De Preter; Jo Vandesompele
Neuroblastoma genetics and phenotype: a tale of heterogeneity.
Seminars in cancer biology 2011;21(4):238-44.
2011: An De Weer; Marta Jeison; Torsten A Konrad; Frédéric Lambert; Pieter Mestdagh; Lucien Noens; Maria Odero; Jan Philippé; Hélène-Antoine Poirel; Bruce Poppe; Pieter Rondou; Maria García Sánchez; Tom Taghon; Joni Van der Meulen; Tom Van Maerken; Nadine Van Roy; Pieter Van Vlierberghe; Peter Vandenberghe; Jo Vandesompele; Bruno Verhasselt; Rotraud Wieser; Isaac Yaniv; Barbara Cauwelier; Nicole Dastugue; Anne De Paepe; Katleen De Preter; Frank Speleman
EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.
British journal of haematology 2011;154(3):337-48.
2011: Joëlle Vermeulen; Katleen De Preter; Steve Lefever; Justine Nuytens; Fanny De Vloed; Stefaan Derveaux; Jan Hellemans; Frank Speleman; Jo Vandesompele
Measurable impact of RNA quality on gene expression results from quantitative PCR.
Nucleic acids research 2011;39(9):e63.
2011: Frida Abel; Daniel Dalevi; Maria Nethander; Rebecka Jörnsten; Katleen De Preter; Joëlle Vermeulen; Raymond Stallings; Per Kogner; John M Maris; Staffan Nilsson
A 6-gene signature identifies four molecular subgroups of neuroblastoma.
Cancer cell international 2011;11():9.
2010: Deborah Castelletti; Giulio Fiaschetti; Valeria Di Dato; Urs Ziegler; Candy Kumps; Katleen De Preter; Massimo Zollo; Frank Speleman; Tarek Shalaby; Daniela De Martino; Thorsten Berg; Angelika Eggert; Alexandre Arcaro; Michael A Grotzer
The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumors.
Molecular cancer therapeutics 2010;9(12):3145-57.
2010: Johannes H Schulte; Benjamin Schowe; Pieter Mestdagh; Lars Kaderali; Prabhav Kalaghatgi; Stefanie Schlierf; Joelle Vermeulen; Bent Brockmeyer; Kristian Pajtler; Theresa Thor; Katleen De Preter; Frank Speleman; Katharina Morik; Angelika Eggert; Jo Vandesompele; Alexander Schramm
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.
International journal of cancer. Journal international du cancer 2010;127(10):2374-85.
2010: Joëlle Vermeulen; Katleen De Preter; Pieter Mestdagh; Geneviève Laureys; Frank Speleman; Jo Vandesompele
Predicting outcomes for children with neuroblastoma.
Discovery medicine 2010;10(50):29-36.
2010: Pieter Mestdagh; E Fredlund; Filip Pattyn; A Rihani; T Van Maerken; J Vermeulen; C Kumps; Björn Menten; Katleen De Preter; Alexander Schramm; J Schulte; R Noguera; G Schleiermacher; Isabelle Janoueix-Lerosey; Geneviève Laureys; R Powel; D Nittner; Jean-Christophe Marine; M Ringnér; F Speleman; Jo Vandesompele
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours.
Oncogene 2010;29(24):3583-92.
2010: Patrick Buckley; Leah Alcock; Kenneth Bryan; Isabella Bray; Johannes H Schulte; Alexander Schramm; Angelika Eggert; Pieter Mestdagh; Katleen De Preter; Jo Vandesompele; Frank Speleman; Raymond L Stallings
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):2971-8.
2010: Pieter Mestdagh; E Fredlund; Filip Pattyn; Johannes H Schulte; D Muth; J Vermeulen; C Kumps; S Schlierf; Katleen De Preter; Nadine Van Roy; R Noguera; Geneviève Laureys; Alexander Schramm; Angelika Eggert; F Westermann; Frank Speleman; Jo Vandesompele
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
Oncogene 2010;29(9):1394-404.
2010: Katleen De Preter; Joëlle Vermeulen; Benedikt Brors; Olivier Delattre; Angelika Eggert; Matthias Fischer; Isabelle Janoueix-Lerosey; Cinzia Lavarino; John M Maris; Jaume Mora; Akira Nakagawara; André Oberthuer; Miki Ohira; Gudrun Schleiermacher; Alexander Schramm; Johannes H Schulte; Qun Wang; Frank Westermann; Frank Speleman; Jo Vandesompele
Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1532-41.
2010: Candy Kumps; Nadine Van Roy; Lien Heyrman; Dirk Goossens; Jurgen Del-Favero; Rosa Noguera; Jo Vandesompele; Frank Speleman; Katleen De Preter
Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma.
BMC genomics 2010;11():298.
2009: Pieter Van Vlierberghe; An De Weer; Pieter Mestdagh; Tom Feys; Katleen De Preter; Pascale De Paepe; Kathleen Lambein; Jo Vandesompele; Nadine Van Roy; Bruno Verhasselt; Bruce Poppe; Frank Speleman
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
British journal of haematology 2009;147(5):686-90.
2009: Joëlle Vermeulen; Katleen De Preter; Geneviève Laureys; Frank Speleman; Jo Vandesompele
59-gene prognostic signature sub-stratifies high-risk neuroblastoma patients.
The lancet oncology 2009;10(11):1030.
2009: Joëlle Vermeulen; Filip Pattyn; Katleen De Preter; Liesbeth Vercruysse; Stefaan Derveaux; Pieter Mestdagh; Steve Lefever; Jan Hellemans; Frank Speleman; Jo Vandesompele
External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data.
Nucleic acids research 2009;37(21):e138.
2009: Katleen De Preter; Sara De Brouwer; Tom Van Maerken; Filip Pattyn; Alexander Schramm; Angelika Eggert; Jo Vandesompele; Frank Speleman
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3690-6.
2009: Joëlle Vermeulen; Stefaan Derveaux; Steve Lefever; Els De Smet; Katleen De Preter; Nurten Yigit; Anne De Paepe; Filip Pattyn; Frank Speleman; Jo Vandesompele
RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts.
BMC research notes 2009;2():235.
2009: Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.
Genome medicine 2009;1(7):74.
2008: Katleen De Preter; Björn Menten; Sara De Brouwer; Candy Kumps; Evi Michels; Nadine Van Roy; Jo Vandesompele; Frank Speleman
Low-cost dedicated mini-arrays for high-throughput analysis of DNA copy-number alterations in neuroblastoma.
Cancer letters 2008;269(1):111-6.
2008: Katleen De Preter; Roland Barriot; Frank Speleman; Jo Vandesompele; Yves Moreau
Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions.
Nucleic acids research 2008;36(7):e43.
2008: Jo Vandesompele; Evi Michels; Katleen De Preter; Björn Menten; Alexander Schramm; Angelika Eggert; Peter F Ambros; Valérie Combaret; Nadine Francotte; Francesca Antonacci; Anne De Paepe; Geneviève Laureys; Frank Speleman; Nadine Van Roy
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics.
International journal of cancer. Journal international du cancer 2008;122(5):1177-82.
2008: Frank Speleman; C Kumps; Karen Buysse; Bruce Poppe; Björn Menten; Katleen De Preter
Copy number alterations and copy number variation in cancer: close encounters of the bad kind.
Cytogenetic and genome research 2008;123(1-4):176-82.
2008: Evi Michels; Jasmien Hoebeeck; Katleen De Preter; Alexander Schramm; Bénédicte Brichard; Anne De Paepe; Angelika Eggert; Geneviève Laureys; Jo Vandesompele; Frank Speleman
CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23.
BMC cancer 2008;8():173.
2007: Evi Michels; Jo Vandesompele; Katleen De Preter; Jasmien Hoebeeck; Joëlle Vermeulen; Alexander Schramm; Jan J Molenaar; Björn Menten; Barbara Marques; Raymond L Stallings; Valérie Combaret; Christine Devalck; Anne De Paepe; Rogier Versteeg; Angelika Eggert; Geneviève Laureys; Nadine Van Roy; Frank Speleman
ArrayCGH-based classification of neuroblastoma into genomic subgroups.
Genes, chromosomes & cancer 2007;46(12):1098-108.
2007: Evi Michels; Katleen De Preter; Nadine Van Roy; Frank Speleman
Detection of DNA copy number alterations in cancer by array comparative genomic hybridization.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(9):574-84.
2007: Tom Feys; Bruce Poppe; Katleen De Preter; Nadine Van Roy; Bruno Verhasselt; Pascale De Paepe; Anne De Paepe; Frank Speleman
A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.
Haematologica 2007;92(7):913-20.
2007: Jasmien Hoebeeck; Evi Michels; Björn Menten; Nadine Van Roy; Angelika Eggert; Alexander Schramm; Katleen De Preter; Nurten Yigit; Els De Smet; Anne De Paepe; Geneviève Laureys; Jo Vandesompele; Frank Speleman
High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.
International journal of cancer. Journal international du cancer 2007;120(3):533-8.
2007: Frank Speleman; Katleen De Preter; Jasmien Hoebeeck; N Van Roy; Jo Vandesompele
[New insights into the genetic basis of neuroblastoma].
Verhandelingen - Koninklijke Academie voor Geneeskunde van België 2007;69(4):167-96.
2006: Jasmien Hoebeeck; Jo Vandesompele; Helén Nilsson; Katleen De Preter; Nadine Van Roy; Els De Smet; Nurten Yigit; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma.
International journal of cancer. Journal international du cancer 2006;119(3):624-9.
2006: Evi Michels; Jo Vandesompele; Jasmien Hoebeeck; Björn Menten; Katleen De Preter; Geneviève Laureys; Nadine Van Roy; Frank Speleman
Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints.
Cytogenetic and genome research 2006;115(3-4):273-82.
2006: Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.
Genome biology 2006;7(9):R84.
2005: Katleen De Preter; Frank Speleman; Valérie Combaret; John Lunec; Julian Board; Andy Pearson; Anne De Paepe; Nadine Van Roy; Geneviève Laureys; Jo Vandesompele
No evidence for correlation of DDX1 gene amplification with improved survival probability in patients with MYCN-amplified neuroblastomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):3167-8; author reply 3168-70.
2005: Jo Vandesompele; Baudis Michael; Katleen De Preter; Nadine Van Roy; Peter F Ambros; Nick Bown; Christian Brinkschmidt; Holger Christiansen; Valérie Combaret; Maria Lastowska; James Nicholson; Anne O'Meara; Dominique Plantaz; Raymond L Stallings; Bénédicte Brichard; Caroline Van den Broecke; Sylvia De Bie; Anne De Paepe; Geneviève Laureys; Frank Speleman
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2280-99.
2005: Katleen De Preter; Jo Vandesompele; Björn Menten; Philippa Carr; Heike Fiegler; Anders Edsjö; Nigel P Carter; Nurten Yigit; Wim Waelput; Nadine Van Roy; Scott Bader; Sven Påhlman; Frank Speleman
Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.
BMC genomics 2005;6():97.
2005: Björn Menten; Filip Pattyn; Katleen De Preter; Piet Robbrecht; Evi Michels; Karen Buysse; Geert R Mortier; Anne De Paepe; Steven Van Vooren; Joris R Vermeesch; Yves Moreau; Bart De Moor; Stefan Vermeulen; Frank Speleman; Jo Vandesompele
arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays.
BMC bioinformatics 2005;6():124.
2004: Katleen De Preter; Jo Vandesompele; Jasmien Hoebeeck; Caroline Vandenbroecke; Joél Smet; Annick Nuyts; Geneviève Laureys; Valérie Combaret; Nadine Van Roy; Frank Roels; Rudy Van Coster; Marleen Praet; Anne De Paepe; Frank Speleman
No evidence for involvement of SDHD in neuroblastoma pathogenesis.
BMC cancer 2004;4():55.
2004: Katleen De Preter; Filip Pattyn; Geert Berx; Kristin Strumane; Björn Menten; Frans van Roy; Anne De Paepe; Frank Speleman; Jo Vandesompele
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons.
BMC genomics 2004;5(1):11.
2003: Katleen De Preter; Jo Vandesompele; Pierre Heimann; Mark M Kockx; Mireille Van Gele; Jasmien Hoebeeck; Els De Smet; Martine Demarche; Geneviève Laureys; Nadine Van Roy; Anne De Paepe; Frank Speleman
Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells.
Cancer letters 2003;197(1-2):53-61.
2003: Jo Vandesompele; Anders Edsjö; Katleen De Preter; Håkan Axelson; Frank Speleman; Sven Påhlman
ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
Oncogene 2003;22(3):456-60.
2003: Frank Roels; Jean-Marie Saudubray; Marisa Giros; Hanna Mandel; François Eyskens; Nieves Saracibar; Begoña Atares Pueyo; Jose M Prats; Betty De Prest; Katleen De Preter; Mercedes Pineda; Pierre Krystkowiak; Jeannette Gootjes; Ronald J A Wanders; Marc Espeel; Bwee Tien Poll-The
Peroxisome mosaics.
Advances in experimental medicine and biology 2003;544():97-106.
2002: Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
Genome biology 2002;3(7):RESEARCH0034.
2002: Katleen De Preter; Frank Speleman; Valérie Combaret; John Lunec; Geneviève Laureys; Bert H J Eussen; Nadine Francotte; Julian Board; Andrew D J Pearson; Anne De Paepe; Nadine Van Roy; Jo Vandesompele
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(2):159-66.